ACUTA CAPITAL PARTNERS, LLC TRML Holdings History
ACUTA CAPITAL PARTNERS, LLC's Tourmaline Bio Inc Holding Summary
As of 2025-03-31, ACUTA CAPITAL PARTNERS, LLC held 426,882.00 shares of Tourmaline Bio Inc(TRML), totaling $6.49 Mil. This investment constitutes 7.53% of their stock portfolio, and ACUTA CAPITAL PARTNERS, LLC now holds 1.66% of the outstanding Tourmaline Bio Inc(TRML) stock.
The initial trade took place in 2023Q4. And since then ACUTA CAPITAL PARTNERS, LLC has made 6 purchases of TRML, at an average price of $18.92, for a total of 426,882.00 shares. Based on historical transaction data and TRML's current price of $18.60, ACUTA CAPITAL PARTNERS, LLC's estimated gain on his TRML holdings is $-134,499.43, reflecting a -1.67% gain to date.
ACUTA CAPITAL PARTNERS, LLC TRML ($18.60) Holding Chart
ACUTA CAPITAL PARTNERS, LLC TRML ($18.60) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
